Baxter International Inc. (BAX) Price Target Analysis

Updated Jun 18, 2026

Analyst Rating: Hold

Based on 36 analysts

4.1% Below Target

BAX trades 4.1% below Wall Street's consensus target of $20.71.

Current Price$19.89

Average Target$20.71

Target

Current

Low$17.00

Median$20.00

High$27.00

Analyst Target Range

Forward P/E10.4x

(Value)

PEG Ratio—

Implied Growth+190.1%

(High Growth)

Analyst Spread48.3%

(Moderate)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$19.89

Consensus$20.71

High$27.00

Low$17.00

Consensus Scenario Assumptions

The base valuation assumes BAX achieves its forward estimates and maintains a stable P/E multiple of 10.4x. This scenario reflects the blended consensus of 36 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 36 published analyst recommendations for BAX

53% hold / mixed conviction

BearishBullish

Weighted analyst sentiment score based on 36 ratings

ConsensusHold

Coverage36 Analysts

Net Score+18

Bull / Bear42% / 6%

Strong Buy00%

Buy1542%

Hold1953%

Sell26%

Strong Sell00%

Strong Buy

00%

Buy

1542%

Hold

1953%

Sell

26%

Strong Sell

00%

Recommendation Mix42% Buy · 53% Hold · 6% Sell

Buy (15)Hold (19)Sell (2)

BAX Price Target Analysis

Updated June 22, 2026

As of June 22, 2026, Baxter International Inc. (BAX) has a Wall Street consensus price target of $20.71, based on estimates from 36 covering analysts. With the stock currently trading at $19.89, this represents a potential upside of +4.1%. The company has a market capitalization of $10.27B.

Analyst price targets range from a low of $17.00 to a high of $27.00, representing a 48% spread in expectations. The median target of $20.00 aligns closely with the consensus average.

The current analyst consensus rating is Hold, with 15 analysts rating the stock as a Buy or Strong Buy,19 rating it Hold, and 2 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.

From a valuation perspective, BAX trades at a trailing P/E of -11.4x and forward P/E of 10.4x. Analysts expect EPS to grow +190.1% over the next year.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis

Avg Peer Upside

+44.0%

Industry Consensus

Avg Forward P/E

15.8x

(Fair)

Peers with Coverage

10 / 10

Active Analyst Tracking

Company	Market Cap	Price	Target	Upside Potential	Rating	Fwd P/E	Analysts
BDXBecton, Dickinson and Company	$52.2B	$143.98	$174.81	+21.4%	Hold	11.4x	34
BSXBoston Scientific Corporation	$67.3B	$45.29	$82.90	+83.0%	Buy	13.5x	44
EWEdwards Lifesciences Corporation	$50.4B	$87.36	$96.55	+10.5%	Buy	29.0x	48
ICUSeaStar Medical Holding Corporation	$122M	$3.12	$8.00	+156.4%	Buy	—	1
HSICHenry Schein, Inc.	$9.2B	$79.92	$87.43	+9.4%	Buy	14.9x	33
HAEHaemonetics Corporation	$3.4B	$74.17	$80.33	+8.3%	Buy	15.0x	21
FMSFresenius Medical Care AG & Co. KGaA	$13.0B	$23.59	$28.00	+18.7%	Hold	11.6x	18
DVADaVita Inc.	$13.3B	$207.91	$202.25	-2.7%	Hold	14.0x	23
HOLXHologic, Inc.	$17.0B	$76.01	$78.69	+3.5%	Hold	17.2x	42
NVCRNovoCure Limited	$1.6B	$14.28	$33.00	+131.1%	Buy	—	15

BAX — Frequently Asked Questions

Quick answers to the most common questions about buying BAX stock.

What is the BAX stock price target for 2026?

The consensus price target for BAX is $20.71, close to the current price of $19.89 (4.1% implied move). Based on 36 analyst estimates, the stock appears fairly valued near current levels.

Is BAX a buy, sell, or hold?

BAX has a consensus rating of "Hold" based on 36 Wall Street analysts. The rating breakdown is mixed, with 19 Hold ratings making up the largest segment. The consensus 12-month price target of $20.71 implies 4.1% upside from current levels.

Is BAX stock overvalued or undervalued?

With a forward P/E of 10.3594x, BAX trades at a relatively low valuation. The consensus target of $20.71 implies 4.1% appreciation, suggesting the market may be pricing in risks.

How high can BAX stock go?

The most bullish Wall Street analyst has a price target of $27 for BAX, while the most conservative target is $17. The consensus of $20.71 represents the median expectation. These targets typically reflect 12-month expectations.

How many analysts cover BAX stock?

BAX is heavily covered by Wall Street, with 36 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 15 have Buy ratings, 19 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the BAX stock forecast?

The 12-month BAX stock forecast based on 36 Wall Street analysts shows a consensus price target of $20.71, with estimates ranging from $17 (bear case) to $27 (bull case). The median consensus rating is "Hold".

What is BAX's forward P/E ratio?

BAX trades at a forward P/E ratio of 10.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy BAX stock?

BAX appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $20.71 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do BAX price targets vary so much?

BAX analyst price targets range from $17 to $27, a 48% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $20.71 consensus represents the middle ground.

Consensus-Based Analysis Tools